Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression
Gabriella Gobbi(McGill University), Stefano Comai(University of Padua), Linda Booij(Centre Hospitalier Universitaire Sainte-Justine), Maykel F. Ghabrash(McGill University Health Centre), Nancy Low(McGill University), John Tabaka(McGill University Health Centre), Nicolás A. Núñez(Mayo Clinic), Pablo Cervantes(Douglas Mental Health University Institute), Stephen Vida(McGill University), Marie Saint-Laurent(McGill University Health Centre), Theodore Kolivakis(McGill University), Jessica Di Sante(Centre Hospitalier Universitaire Sainte-Justine)
Cited by 30
Related Papers
Genome-wide association study identifies 30 loci associated with bipolar disorder
|Nature Genetics|2019|1.6k
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
|Pharmacological Reviews|2018|386